GSDMD and metabolic dysfunction-associated steatohepatitis: These findings imply that hepatic-specific knockout of Glut9 may reduce intrahepatic UA levels, which could subsequently alleviate liver GSDMD-induced hepatocyte pyroptosis and delay the progression of NASH both in vivo and in vitro.